Clinical Trials Browser

Observational × lenvatinib × 30 days × Clear all

NCT06648057 2026-03-18

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT07466225 2026-03-12

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07419932 2026-02-19

NeoLATC

Thyroid Neoplasms